FTAC Zeus Acquisition Corp. (NASDAQ:ZING – Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 15,500 shares, an increase of 192.5% from the November 15th total of 5,300 shares. Based on an average daily trading volume, of 535,400 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company's shares are sold short.

Institutional Investors Weigh In On FTAC Zeus Acquisition

Large investors have recently added to or reduced their stakes in the stock. P Schoenfeld Asset Management LP purchased a new stake in FTAC Zeus Acquisition in the 1st quarter valued at about $1,968,000. TENOR CAPITAL MANAGEMENT Co. L.P. purchased a new stake in shares of FTAC Zeus Acquisition in the 1st quarter worth approximately $4,920,000. HBK Investments L P purchased a new stake in shares of FTAC Zeus Acquisition in the 1st quarter worth approximately $5,904,000. Omni Event Management Ltd purchased a new stake in shares of FTAC Zeus Acquisition in the 1st quarter worth approximately $868,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in shares of FTAC Zeus Acquisition in the 1st quarter worth approximately $985,000.

FTAC Zeus Acquisition Price Performance

FTAC Zeus Acquisition stock opened at $10.04 on Tuesday. FTAC Zeus Acquisition has a 1 year low of $9.72 and a 1 year high of $10.36. The firm has a 50-day moving average of $10.03 and a two-hundred day moving average of $9.94.

About FTAC Zeus Acquisition

FTAC Zeus Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as FTAC Hera Acquisition Corp. and changed its name to FTAC Zeus Acquisition Corp.

Read More

• Get a free copy of the StockNews.com research report on FTAC Zeus Acquisition (ZING)
• It's Still Too Soon to Shop for Kohl's Stock
• Coinbase Global Stock is a Falling Meat Cleaver
• Three Small-Cap Biotech Stocks to Consider Now
• What To Expect From The Q4 Earnings Reporting Season
• Two Blue Chip Health Companies The Institutions Are Buying

Receive News & Ratings for FTAC Zeus Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FTAC Zeus Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.